With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

Major private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition high...

The latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...

Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...

This is easy to say, but difficult to actually implement: As an investor, make a distinction between the day-to-day movement of indices and...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

As nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...

Siemens Healthineers is exiting its Indian cancer care chain, American Oncology Institute. The deal is valued between ₹1,500-2,000 crore. P...

A major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...

Alkem Laboratories has launched Pertuza, a biosimilar of pertuzumab, in India for treating HER2-positive breast cancer. This indigenously d...

Under the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...

When Dr. Lukas Wartman began medical school at Washington University in St. Louis, he knew he wanted to study cancer and treat patients.

'Watson for Oncology' was developed by IBM in association with Memorial Sloan Kettering Cancer Center (MSK), one of the world's leading can...

The oncology market in India is growing at 20 per cent annually and is expected to touch Rs 3,831 crore by 2017.

Corporate healthcare pioneer Apollo Hospitals has invested Rs 75 crore on setting up a speciality cancer hospital in the heart of the city.